BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9629533)

  • 1. 1513-DMIa and 1513-DMIb, DNA methyltransferase inhibitors produced by Streptomyces sp. strain No. 1513.
    Nagao K; Suzuki K; Hamada S; Yahara S; Yamamura R; Uyeda M
    J Enzyme Inhib; 1998 Apr; 13(2):135-46. PubMed ID: 9629533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DMI-2 and DMI-3, DNA methyltransferase inhibitors produced by Streptomyces sp. strain no. 560.
    Nagao K; Suzuki K; Tokunaga J; Miyazaki H; Katayama N; Mitsuyama R; Uyeda M
    J Enzyme Inhib; 1996; 10(2):115-24. PubMed ID: 8835936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DMI-1, a new DNA methyltransferase inhibitor produced by Streptomyces sp. strain No. 560.
    Suzuki K; Nagao K; Tokunaga J; Hirosawa M; Tsubone H; Uyeda M
    J Enzyme Inhib; 1995; 9(4):243-52. PubMed ID: 8598534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of DNA methyltransferase by microbial inhibitors and fatty acids.
    Suzuki K; Nagao K; Tokunaga J; Katayama N; Uyeda M
    J Enzyme Inhib; 1996; 10(4):271-280. PubMed ID: 8872747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatoquinones A and B, novel tyrosine phosphatase inhibitors produced by Streptomyces sp.
    Kagamizono T; Hamaguchi T; Ando T; Sugawara K; Adachi T; Osada H
    J Antibiot (Tokyo); 1999 Feb; 52(2):75-80. PubMed ID: 10344559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxyribonuclease inhibitors produced by streptomycetes.
    Suzuki K; Nagao K; Goto M; Uyeda M
    J Enzyme Inhib; 1993; 7(1):27-32. PubMed ID: 7510791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNF-4794: new enzyme inhibitors produced by Chaetomella sp.
    Esumi Y; Suzuki Y; Ichikawa T; Ikeda Y; Kimura K
    J Antibiot (Tokyo); 2003 Feb; 56(2):169-72. PubMed ID: 12715877
    [No Abstract]   [Full Text] [Related]  

  • 8. UCF116, new inhibitors of farnesyltransferase produced by Streptomyces.
    Hara M; Soga S; Itoh M; Shono K; Eishima J; Mizukami T
    J Antibiot (Tokyo); 2000 Jul; 53(7):720-3. PubMed ID: 10994815
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of DNA topoisomerases by microbial inhibitors.
    Suzuki K; Siddique T; Nishimura H; Sekimoto J; Uyeda M
    J Enzyme Inhib; 1998 Feb; 13(1):41-55. PubMed ID: 9879513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yatakemycin, a novel antifungal antibiotic produced by Streptomyces sp. TP-A0356.
    Igarashi Y; Futamata K; Fujita T; Sekine A; Senda H; Naoki H; Furumai T
    J Antibiot (Tokyo); 2003 Feb; 56(2):107-13. PubMed ID: 12715869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abenquines A-D: aminoquinone derivatives produced by Streptomyces sp. strain DB634.
    Schulz D; Beese P; Ohlendorf B; Erhard A; Zinecker H; Dorador C; Imhoff JF
    J Antibiot (Tokyo); 2011 Dec; 64(12):763-8. PubMed ID: 21952099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel phospholipase C inhibitor, S-PLI produced by Streptomyces sp. strain no. A-6288.
    Suzuki K; Siddique T; Ohya S; Kaneko M; Maruyama S; Shoji S; Uyeda M
    J Enzyme Inhib; 1996; 10(3):177-86. PubMed ID: 8835943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new cytosine glycoside from Streptomyces griseochromogenes produced by the use in vivo of enzyme inhibitors.
    Zhang Q; Gould SJ; Zabriskie TM
    J Nat Prod; 1998 May; 61(5):648-51. PubMed ID: 9599268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atacamycins A-C, 22-membered antitumor macrolactones produced by Streptomyces sp. C38.
    Nachtigall J; Kulik A; Helaly S; Bull AT; Goodfellow M; Asenjo JA; Maier A; Wiese J; Imhoff JF; Süssmuth RD; Fiedler HP
    J Antibiot (Tokyo); 2011 Dec; 64(12):775-80. PubMed ID: 22008702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potent seryl tRNA synthetase inhibitor SB-217452 isolated from a Streptomyces species.
    Stefanska AL; Fulston M; Houge-Frydrych CS; Jones JJ; Warr SR
    J Antibiot (Tokyo); 2000 Dec; 53(12):1346-53. PubMed ID: 11217799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hatomarubigin E, a biosynthetic intermediate of hatomarubigins C and a substrate of HrbU O-methyltransferase.
    Kawasaki T; Yamada Y; Maruta T; Maeda A; Hayakawa Y
    J Antibiot (Tokyo); 2010 Dec; 63(12):725-7. PubMed ID: 20959847
    [No Abstract]   [Full Text] [Related]  

  • 17. Panowamycins A and B, new antitrypanosomal isochromans produced by Streptomyces sp. K07-0010.
    Hashida J; Niitsuma M; Iwatsuki M; Mori M; Ishiyama A; Namatame M; Nishihara-Tsukashima A; Matsumoto A; Ara I; Takahashi Y; Yamada H; Otoguro K; Shiomi K; Omura S
    J Antibiot (Tokyo); 2012 Apr; 65(4):197-202. PubMed ID: 22274704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel naphthoquinones from a Streptomyces sp.
    Kulanthaivel P; Perun TJ; Belvo MD; Strobel RJ; Paul DC; Williams DC
    J Antibiot (Tokyo); 1999 Mar; 52(3):256-62. PubMed ID: 10348040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyl-3,4-dihydroxy-L-phenylalanine, a second identified bioactive metabolite produced by Streptomyces sp. 8812.
    Solecka J; Rajnisz A; Postek M; Zajko J; Kawecki R; Havlicek V; Bednarek E; Kozerski L
    J Antibiot (Tokyo); 2012 Apr; 65(4):219-21. PubMed ID: 22293914
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of rationally designed DNA N6 adenine methyltransferase inhibitors.
    Hobley G; McKelvie JC; Harmer JE; Howe J; Oyston PC; Roach PL
    Bioorg Med Chem Lett; 2012 May; 22(9):3079-82. PubMed ID: 22483584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.